Get 10% off For taking quiz
FREE SHIPPING & RETURNS
on all orders over $75.
MONEY BACK GUARANTEE
100% money back guarantee.
Support 24/7
customersuccess@countrywidetesting.com

Transit Drug Policy Examples for Employers: A Compliance Guide

by Stephanie

TL;DR:

  • A compliant transit drug policy must align with federal regulations, covering specific testing events, drug classes, and chain-of-custody procedures. It should include clear purpose, definitions, testing requirements, consequences, confidentiality, and review processes, supported by SAMHSA-certified labs and certified collection sites. Differentiating employee testing from passenger conduct policies is essential, and procedural details like documentation and vendor verification ensure program defensibility.

A compliant transit drug policy is a written program aligned with 49 CFR Part 655 and 49 CFR Part 40 that defines scope, required testing events, the five DOT drug classes, chain-of-custody procedures, and a return-to-duty pathway through a Substance Abuse Professional (SAP). Whether you’re drafting a new policy or auditing an existing one, these are the non-negotiable anchors.

At a glance — what every compliant transit drug policy must include:

  • Testing events: Pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up
  • Specimen types: Urine and breath alcohol (oral fluid authorized as a federal alternative since May 2023)
  • Drug classes: Marijuana/cannabinoids, cocaine, amphetamines, opioids, phencyclidine (PCP)
  • Governing bodies: Federal Transit Administration (FTA), DOT Office of Drug & Alcohol Policy & Compliance (ODAPC), SAMHSA
  • Testing support: Countrywidetesting provides compliant kits and certified lab services mapped to these requirements

Table of Contents

What does a complete transit drug and alcohol policy actually contain?

Every compliant policy has the same structural skeleton, regardless of agency size. The FTA’s Best Practices Appendix A includes 12 updated policy examples ranging from large urban systems to small rural operators — and all of them share these core sections:

  • Purpose and scope: Identifies the agency’s mission, cites the Drug-Free Workplace Act of 1988 and the Omnibus Transportation Employee Testing Act of 1991, and names 49 CFR Part 655 and Part 40 as governing regulations. Specifies which positions are safety-sensitive and how contractors are handled.
  • Definitions: Spells out “safety-sensitive duty,” “covered employee,” “prohibited substances,” and the positive-result thresholds set by Part 40.
  • Testing matrix: Lists all required testing events with triggers and timing rules.
  • Consequences: States whether the agency applies zero tolerance or a second-chance program, and ties both to the SAP referral process.
  • Confidentiality and recordkeeping: Sets retention timelines and limits who can access results.
  • Annual review: Commits the agency to reviewing the policy each year against ODAPC updates.
  • Education and training: Requires supervisor training for reasonable suspicion determinations with accredited courses like those offered in the CNESST Training: First aid in the workplace Program.

Pro Tip: Separate any company-authority provisions (testing beyond the federal minimum) from FTA-mandated sections by underlining or labeling them clearly. The Town of Truckee/Tahoe Truckee Area Regional Transit policy uses this exact approach, marking non-DOT provisions so auditors can distinguish them at a glance.

Which substances, testing events, and specimen types does federal law require?

Under 49 CFR Part 655 and Part 40, covered transit employees must be tested for five drug classes, and breath alcohol testing is mandatory for alcohol.

The five DOT drug classes:

  1. Marijuana (cannabinoids/THC)
  2. Cocaine
  3. Amphetamines (including methamphetamine and MDMA)
  4. Opioids (including heroin, codeine, morphine, hydrocodone, oxycodone, and hydromorphone)
  5. Phencyclidine (PCP)

Required testing events:

  • Pre-employment: Before a new hire performs any safety-sensitive function
  • Random: Unannounced draws from a pool of covered employees; DOT sets minimum annual rates by mode
  • Post-accident: Triggered by fatalities or specific injury/damage thresholds
  • Reasonable suspicion: Based on a trained supervisor’s documented observations
  • Return-to-duty and follow-up: After a violation, before resuming safety-sensitive work, plus unannounced follow-up tests

Specimen types: Urine and breath are the standard collection methods. A May 2023 federal rule authorized oral fluid testing as an alternative in certain federal contexts. For kit buyers, this means you can now source oral fluid collection devices for some testing events — though urine remains the default for most DOT-regulated programs. Confirm with your lab that oral fluid kits carry the appropriate accreditation before purchasing.

How do public-facing transit codes of conduct differ from employee testing programs?

These two types of policies serve entirely different purposes and use different enforcement tools. Conflating them is one of the most common mistakes transit HR teams make when procuring testing services.

  • Public-facing codes of conduct govern passenger behavior on transit property. They prohibit drug use, smoking, and disorderly conduct, and enforcement is handled by security staff or police. A 2020 survey of 115 U.S. transit agencies found that contracts with police departments were the most common external partnership, accounting for a majority of agencies surveyed. These rules do not involve laboratory drug testing.
  • Employee testing programs are regulated by FTA and DOT, require certified laboratories, chain-of-custody documentation, Medical Review Officer (MRO) review, and formal testing events as defined in Part 655 and Part 40.

For buyers, the practical split is clear:

  • Public-safety signage, conduct policies, and law enforcement agreements are separate procurement decisions
  • Lab-processed drug tests, collection kits, and MRO services apply exclusively to the employee testing program

Purchasing a multi-panel cup test for passenger screening is not a substitute for a certified lab program for staff. The two tracks should never be mixed.

Sample policy clauses you can adapt for your own documents

Real-world transit policies use modular, cite-specific language. Below are five short template clauses drawn from FTA-reviewed policy examples and the Annapolis Transit Drug and Alcohol Testing Policy:

Hands holding multi-panel drug test cup

Clause Sample language
Purpose/scope “This policy establishes a drug- and alcohol-free workplace in compliance with 49 CFR Part 655 and Part 40. It applies to all employees performing safety-sensitive functions.”
Prohibited substances “Covered employees are prohibited from using marijuana, cocaine, amphetamines, opioids, and PCP at any time, consistent with 49 CFR Part 655.”
Testing events “Employees are subject to pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up testing under FTA authority.”
SAP/return-to-duty “Any employee with a verified positive result must be referred to a DOT-qualified Substance Abuse Professional and may not return to safety-sensitive duty until cleared.”
Confidentiality/records “Test results are confidential and retained for a minimum of five years for drug records and two years for alcohol records, per Part 40 requirements.”

Before signing any lab or kit vendor, verify:

  • HHS/SAMHSA lab certification (required for DOT-regulated urine testing)
  • CLIA, CAP, or ISO accreditation for additional quality assurance
  • Capability for direct-observation collection (required for return-to-duty and follow-up testing)
  • Non-Federal COC forms available for company-authority expanded panels

On zero tolerance vs. second-chance language: federal regulations do not mandate termination. DOT ODAPC guidance makes clear that employers can define second-chance programs, provided the policy states this consistently and applies it uniformly. Valley Metro (LRGVDC) applies strict zero tolerance and terminates employees with confirmed positives; the Town of Truckee policy allows for SAP referral and return. Both are compliant — what matters is that your written policy is unambiguous and consistently enforced.

Why chain of custody and lab credentials determine whether results hold up

Procedural defensibility rests on documented chain of custody, correct COC form selection, certified labs, and proper MRO procedures. Auditors and arbitrators examine these details before accepting any result.

  • DOT vs. non-DOT COC forms: Using a DOT Custody and Control Form for non-Federal testing is a frequent error that can invalidate results. Company-authority testing — including expanded panels beyond the five DOT classes — must use non-Federal COC forms and be kept entirely separate from DOT testing.
  • Lab credentials to require: SAMHSA/HHS certification for urine specimens, plus CLIA, CAP, or ISO accreditation. The FMCSA overview of drug and alcohol rules reinforces that only HHS-certified labs may process DOT specimens.
  • MRO responsibilities: The MRO contacts the donor before transmitting a positive result to the employer, giving the employee an opportunity to provide a valid medical explanation (such as a legitimate prescription). Policies should explicitly name this step to protect due process. Learn more about the full DOT drug test process and MRO workflow.
  • Recordkeeping: Retain drug test records for five years, alcohol records for two years, and supervisor reasonable-suspicion documentation in writing, signed and dated.

Pro Tip: Include a COC audit checklist in your vendor contract: confirm that every specimen leaves the collection site with a sealed, labeled container; that the COC form is complete and signed at each transfer point; and that the lab’s HHS certification number appears on the lab report.

For a deeper look at chain-of-custody procedures and audit readiness, Countrywidetesting’s compliance resources walk through each documentation step.

How to implement and maintain a compliant transit drug testing program

The goal is a defensible, fully operational program before the first covered employee starts safety-sensitive work. Follow this sequence:

  1. Assign a Designated Employer Representative (DER) who owns the program, receives test results, and makes removal decisions.
  2. Identify all safety-sensitive positions and document them in the policy’s applicability section.
  3. Select a certified collection site and lab — confirm SAMHSA/HHS certification, CLIA/CAP/ISO accreditation, and support for urine, breath, and oral fluid collection.
  4. Set up the random testing pool with a defensible, truly random selection mechanism; document the draw process and retain records.
  5. Train supervisors on reasonable suspicion identification before they supervise any covered employee. FMCSA implementation guidelines specify that supervisors must be trained to recognize signs of impairment.
  6. Distribute the written policy to every covered employee and obtain signed acknowledgments.
  7. Schedule an annual policy review tied to ODAPC update cycles.

Vendor selection checklist:

  • Proof of current SAMHSA/HHS lab certification
  • Turnaround time commitments in writing
  • Observed collection capability for return-to-duty and follow-up events
  • Secure electronic results reporting with audit trail
  • Non-Federal COC forms available for company-authority panels

For a full compliance workflow guide, Countrywidetesting has published a step-by-step resource specifically for transit employers.

Key Takeaways

Every transit drug policy must cite 49 CFR Part 655 and Part 40, cover all six testing events, name the five DOT drug classes, and require SAMHSA/HHS-certified lab processing with documented chain of custody.

Point Details
Regulatory anchors Policies must cite 49 CFR Part 655 and Part 40 and cover all required testing events.
Five DOT drug classes Test for marijuana, cocaine, amphetamines, opioids, and PCP — no substitutions permitted.
Lab accreditation Require SAMHSA/HHS certification plus CLIA, CAP, or ISO accreditation in every vendor contract.
COC form discipline Use DOT COC forms only for federal testing; non-Federal panels require separate non-DOT forms.
Countrywidetesting Provides compliant urine and oral fluid kits, certified lab services, and COC support for transit employers.

What transit compliance actually demands from employers

The most underappreciated gap in transit drug policy isn’t the policy document itself — it’s the procedural infrastructure behind it. Agencies spend weeks drafting purpose clauses and consequence language, then sign a vendor contract without verifying SAMHSA certification or confirming that the collection site can perform observed collections for return-to-duty events. That’s where programs unravel.

Federal regulations give employers more flexibility than most HR teams realize. Zero tolerance is a policy choice, not a legal mandate. A well-written second-chance program, consistently applied and tied to a documented SAP referral, is fully compliant. The risk isn’t leniency — it’s inconsistency. Apply the same standard to every employee in the same situation, document every step, and the policy holds.

Oral fluid testing is worth watching closely. The May 2023 federal authorization opened a practical door for employers who struggle with observed urine collection logistics. But the accreditation requirements for oral fluid labs are still evolving, so confirm current HHS status with any vendor before committing to that specimen type at scale.

Countrywidetesting makes compliant testing straightforward for transit employers

Transit employers need more than a policy template — they need kits that meet federal standards and labs that can back them up in an audit. Countrywidetesting sells certified lab testing services processed by SAMHSA, CLIA, CAP, and ISO-accredited facilities, along with urine and multi-panel kits suited for both DOT-regulated and company-authority testing programs.

Countrywidetesting

For employers running expanded panels beyond the five DOT classes, Countrywidetesting also carries non-DOT collection options with the correct chain-of-custody documentation. Enterprise buyers can request custom quotes for high-volume programs. Visit Countrywidetesting to review available lab services, request a quote, or order kits that align with your FTA compliance requirements.

Authoritative sources and further reading

Verify your policy language against primary regulatory sources and review them each time ODAPC publishes updates.

  • 49 CFR Part 655 — FTA Drug & Alcohol Regulations (with Q&A)
  • 49 CFR Part 40 — DOT Procedures for Workplace Drug and Alcohol Testing
  • FTA Drug & Alcohol Program Overview
  • DOT ODAPC — SAP and Return-to-Duty Guidance (§ 40.305)
  • FTA Best Practices — Example Policies, Appendix A
  • Annapolis Transit Drug and Alcohol Testing Policy
  • FMCSA Implementation Guidelines — Chapter 5 (Supervisor Training)

Review these sources annually. ODAPC updates Part 40 guidance periodically, and any change to testing rates, specimen types, or MRO procedures should trigger an immediate policy review.

Back to Learning Center